How Funding and Mentorship Forged a New Path to Fight Cancer
Read the latest interview of our PI and CEO, Dr Awah with Susan Schulz on UTR Therapeutics Inc. progress on advancing our novel drugs through the regulatory pathways and the discovery of UTR novel mRNA platform and the many exciting things it has created. Many thanks to Seema Kumar , the CEO of CURE and CURE and the Deerfield Management for organizing this.
Overview
Nigerian-born Chidiebere Awah, MD, PhD, CEO of UTR Therapeutics Inc., has created a technology with potential to not only take on aggressive cancers, but also Alzheimer’s disease, metabolic diseases and more.
